Singh Tanu, Ichhpujani Parul, Singh Rohan Bir, Arya Sudesh, Kumar Suresh
Assistant Professor, Department of Ophthalmology, Government Medical College and Hospital, Sector-32, Chandigarh 160030, India.
Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India.
Ther Adv Ophthalmol. 2023 Feb 7;15:25158414221147823. doi: 10.1177/25158414221147823. eCollection 2023 Jan-Dec.
Ultra-thin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) is a recently developed surgical procedure that has shown promising results for the management of various corneal endothelial diseases.
To evaluate the outcomes of the UT-DSAEK to the Descemet membrane endothelial keratoplasty (DMEK).
A systematic analysis of the studies comparing UT-DSAEK with DMEK by evaluating one or more outcomes (vision, complications, and post-operative endothelial cell counts) was performed. The meta-analysis was done if two or more studies reported a common outcome.
We used PubMed, EMBASE, and SCOPUS databases to identify articles comparing the outcomes of UT-DSAEK with DMEK and performed a meta-analysis using RevMan, version 5.4.
A total of six studies were included in this review (two randomized clinical trials and four non-randomized comparative studies). Our analysis showed the patients who underwent DMEK cases showed better visual outcomes with a mean difference of 0.06 LogMAR (95% CI: 0.04-0.09) in BCVA, albeit with of 52% (heterogenous values). The evidence was weak, with the most weightage on retrospective studies. UT-DSAEK showed significantly fewer complications such as graft dislocations, with an odds ratio of 0.25 (95% CI: 0.13-0.48). There was no significant difference in the endothelial cell counts with a mean difference of 86.34 (95%CI: -133.09 to -305.77).
Although the literature is limited on UT-DSAEK with post-operative visual acuity that could be practically at par with DMEK, lesser complication rates and comparable post-operative endothelial cells could be a suitable alternative to DMEK for corneal endothelial pathologies.
超薄Descemet膜剥除自动内皮角膜移植术(UT-DSAEK)是一种最近开发的外科手术,已显示出在治疗各种角膜内皮疾病方面的良好效果。
评估UT-DSAEK与Descemet膜内皮角膜移植术(DMEK)的疗效。
通过评估一项或多项结果(视力、并发症和术后内皮细胞计数)对比较UT-DSAEK与DMEK的研究进行系统分析。如果两项或更多研究报告了共同结果,则进行荟萃分析。
我们使用PubMed、EMBASE和SCOPUS数据库来识别比较UT-DSAEK与DMEK结果的文章,并使用RevMan 5.4版进行荟萃分析。
本综述共纳入六项研究(两项随机临床试验和四项非随机对照研究)。我们的分析表明,接受DMEK手术的患者视力结果更好,最佳矫正视力(BCVA)的平均差异为0.06 LogMAR(95%可信区间:0.04-0.09),尽管异质性值为52%。证据薄弱,回顾性研究权重最大。UT-DSAEK显示出显著较少的并发症,如植片脱位,优势比为0.25(95%可信区间:0.13-0.48)。内皮细胞计数无显著差异,平均差异为86.34(95%可信区间:-133.09至-305.77)。
尽管关于UT-DSAEK术后视力与DMEK实际相当的文献有限,但较低的并发症发生率和相当的术后内皮细胞数量可能是治疗角膜内皮病变的DMEK的合适替代方法。